News

July 11, 2017July 11, 2017

Trial Underway in Rare Lung Disease That Can Cause PF and Targets People from Puerto Rico

News

Vanderbilt University researchers are sponsoring the first major study of a rare lung disease that disproportionately affects people from Puerto Rico and can cause pulmonary fibrosis. Called Hermansky-Pudlak syndrome (HPS), the ... Read more

July 7, 2017July 7, 2017

Vectura Signs Agreement with Sandoz to Develop Generic Combination Therapy for Asthma and COPD in the U.S.

News

A generic version of an existing inhaled combination therapy for asthma and chronic obstructive pulmonary disease (COPD) will be developed in the United States under an agreement between Vectura Group subsidiary Jagotec ... Read more

July 6, 2017July 6, 2017

Study Supports the Development of Envisia Genomic Classifier for IPF Diagnosis

Idiopathic Pulmonary Fibrosis, News

Veracyte recently announced that results from a study supporting the development of the Envisia Genomic Classifier, a genomic test used to improve the diagnosis of idiopathic pulmonary fibrosis (IPF), have been ... Read more

July 5, 2017July 5, 2017

Respiratory Hospitalization Rates May Improve Outcome Assessments in IPF Trials, Researchers Suggest

Idiopathic Pulmonary Fibrosis, News

Researchers at Columbia University propose that respiratory-related hospitalization rates are an important “patient-centered” outcome measure that should be considered in clinical trials assessing treatment effectiveness in patients with idiopathic pulmonary fibrosis (IPF), ... Read more

June 30, 2017June 30, 2017

New Esbriet Tablets for IPF Treatment Now Available in Europe

Idiopathic Pulmonary Fibrosis, News

The European Commission has approved a new formulation of Esbriet (pirfenidone) tablets for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF). Esbriet, developed by Roche, is an oral antifibrotic medication approved ... Read more

June 29, 2017June 29, 2017

Traditional Chinese Medicine Therapy Can Help Slow PF Progression, Study Finds

Idiopathic Pulmonary Fibrosis, News

Pulmonary rehabilitation mixture (PRM), an herbal-based formula used for decades in Chinese traditional medicine, has therapeutic potential against pulmonary fibrosis (PF) progression by targeting several molecular factors known to be involved ... Read more

June 28, 2017June 28, 2017

Childhood Asthma Found to Increase Risk of Heart Thickening in Adulthood

Asthma, News

Researchers have found an association between childhood asthma and a greater risk of thickening of the left ventricle in the heart, particularly in patients with prehypertension and hypertension. Thickening of the ... Read more

June 28, 2017June 28, 2017

Washington University to Sequence DNA of Lung Disease Patients Across Ethnic Groups

COPD, Idiopathic Pulmonary Fibrosis, News

The McDonnell Genome Institute at Washington University has received a $10 million U.S. government grant to map the DNA of patients from a number of ethnic groups who had chronic obstructive pulmonary disease ... Read more

June 27, 2017June 27, 2017

FDA Approves Tafinlar/Mekinist Combo to Treat Specific Type of Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) approved the combination therapy Tafinlar (dabrafenib) and Mekinist (trametinib) as a treatment for patients with metastatic non-small cell lung cancer (NSCLC) carrying specific ... Read more

June 23, 2017June 23, 2017

Pulmonary Fibrosis Patients May Have Genetic Susceptibility to Lung Cancer, Study Shows

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Pulmonary fibrosis (PF) patients with lung cancer have alterations in 14 cancer-driver genes, a new French study analyzing cancer samples from PF patients reported. The study is titled, “Morphologic and molecular study of lung ... Read more